In conclusion, in AMD patients with SMHs, the use of anticoagulant medication, large-diameter hemorrhage, and disease of the PCV subtype, were risk factors for breakthrough VH after anti-VEGF injection. The gene discussed is VEGFA; the disease is age-related macular degeneration.